Tirzepatide as Compared with Semaglutide for the Treatment of Obesity.
Saved in:
| Title: | Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. |
|---|---|
| Authors: | Aronne LJ; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York., Horn DB; University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston., le Roux CW; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin.; Diabetes Research Centre, Ulster University, Coleraine, United Kingdom., Ho W; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles.; David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles., Falcon BL; Eli Lilly, Indianapolis., Gomez Valderas E; Eli Lilly, Indianapolis., Das S; Eli Lilly, Indianapolis., Lee CJ; Eli Lilly, Indianapolis., Glass LC; Eli Lilly, Indianapolis., Senyucel C; Eli Lilly, Indianapolis., Dunn JP; Eli Lilly, Indianapolis. |
| Corporate Authors: | SURMOUNT-5 Trial Investigators |
| Source: | The New England journal of medicine [N Engl J Med] 2025 Jul 03; Vol. 393 (1), pp. 26-36. Date of Electronic Publication: 2025 May 11. |
| Publication Type: | Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study |
| Journal Info: | Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40353578 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Aronne+LJ%22">Aronne LJ</searchLink>; Comprehensive Weight Control Center, Division of Endocrinology, Diabetes and Metabolism, Weill Cornell Medicine, New York.<br /><searchLink fieldCode="AU" term="%22Horn+DB%22">Horn DB</searchLink>; University of Texas Center for Obesity Medicine and Metabolic Performance, Department of Surgery, University of Texas McGovern Medical School, Houston.<br /><searchLink fieldCode="AU" term="%22le+Roux+CW%22">le Roux CW</searchLink>; Diabetes Complications Research Centre, Conway Institute, University College Dublin, Dublin.; Diabetes Research Centre, Ulster University, Coleraine, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ho+W%22">Ho W</searchLink>; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles.; David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles.<br /><searchLink fieldCode="AU" term="%22Falcon+BL%22">Falcon BL</searchLink>; Eli Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Gomez+Valderas+E%22">Gomez Valderas E</searchLink>; Eli Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Das+S%22">Das S</searchLink>; Eli Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Lee+CJ%22">Lee CJ</searchLink>; Eli Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Glass+LC%22">Glass LC</searchLink>; Eli Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Senyucel+C%22">Senyucel C</searchLink>; Eli Lilly, Indianapolis.<br /><searchLink fieldCode="AU" term="%22Dunn+JP%22">Dunn JP</searchLink>; Eli Lilly, Indianapolis. – Name: AuthorCorporate Label: Corporate Authors Group: Au Data: <searchLink fieldCode="CA" term="%22SURMOUNT-5+Trial+Investigators%22">SURMOUNT-5 Trial Investigators</searchLink> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%220255562%22">The New England journal of medicine</searchLink> [N Engl J Med] 2025 Jul 03; Vol. 393 (1), pp. 26-36. <i>Date of Electronic Publication: </i>2025 May 11. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Comparative Study; Equivalence Trial; Journal Article; Multicenter Study – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Massachusetts+Medical+Society%22">Massachusetts Medical Society </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0255562 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1533-4406 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200284793%22">00284793 </searchLink><i>NLM ISO Abbreviation: </i>N Engl J Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40353578 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1056/NEJMoa2416394 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 26 Titles: – TitleFull: Tirzepatide as Compared with Semaglutide for the Treatment of Obesity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Aronne LJ – PersonEntity: Name: NameFull: Horn DB – PersonEntity: Name: NameFull: le Roux CW – PersonEntity: Name: NameFull: Ho W – PersonEntity: Name: NameFull: Falcon BL – PersonEntity: Name: NameFull: Gomez Valderas E – PersonEntity: Name: NameFull: Das S – PersonEntity: Name: NameFull: Lee CJ – PersonEntity: Name: NameFull: Glass LC – PersonEntity: Name: NameFull: Senyucel C – PersonEntity: Name: NameFull: Dunn JP IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 07 Text: 2025 Jul 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1533-4406 Numbering: – Type: volume Value: 393 – Type: issue Value: 1 Titles: – TitleFull: The New England journal of medicine Type: main |
| ResultId | 1 |